文献速递外周动脉疾病

BEST-CLI主要不良心脏事件风险计算器在VQI与VISION中的外部验证

External Validation of the BEST-CLI Major Adverse Cardiac Risk Calculator in the Vascular Quality Initiative and Vascular Implant Surveillance and Interventional Outcomes Network.
PubMed 文献 · Ann Vasc Surg · 2026-07-27

本研究将BEST-CLI队列衍生的1年主要不良心脏事件(MACE)模型在VQI-VISION外周血管介入与腹股沟下登记(2016-2019)中外部验证,纳入19,144例患者。结果显示模型区分度中等(C-index 0.62),校准欠佳(斜率0.54,截距0.31),平均低估1年MACE 8.6%。

要点

  • BEST-CLI MACE模型在真实世界血管实践中区分度中等(C-index 0.62)。
  • 模型平均低估1年MACE 8.6%(95%CI 8.5%-8.7%),校准欠佳。
  • VQI-VISION队列1年复合MACE发生率为32.6%(95%CI 31.9%-33.3%)。

核心结论

  • BEST-CLI 1年MACE评分系统在真实世界血管实践中预测能力中等,模型平均低估1年MACE 8.6%。

研究设计与样本

  • 在VQI-VISION外周血管介入与腹股沟下登记(2016-2019)中外部验证BEST-CLI 1年MACE模型。
  • 纳入19,144例 eligible 患者,其中腔内治疗14,878例(77.7%),开放手术4,266例(22.3%)。
  • 采用Kaplan-Meier分析计算观察1年MACE率,以Cox校准斜率与截距及Harrel's C-index评估校准与区分度。

主要发现

  • Kaplan-Meier估计1年死亡率为25.3%(95%CI 24.6%-25.9%)。
  • Kaplan-Meier估计1年心肌梗死(MI)率为10.3%(95%CI 9.8%-10.8%)。
  • Kaplan-Meier估计1年脑血管意外(CVA)率为4.9%(95%CI 4.6%-5.3%)。
  • 复合MACE发生率为32.6%(95%CI 31.9%-33.3%)。
  • BEST-CLI MACE评分范围为-4至23(中位数9,四分位距5-13);观察1年MACE较BEST-CLI估计值平均高8.6%(95%CI 8.5%-8.7%);校准斜率0.54,截距0.31,C-index 0.62。

临床怎么用

  • 临床使用BEST-CLI MACE计算器时需注意其在真实世界中可能低估1年MACE风险约8.6%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To perform external validation of the 1-year major adverse cardiac event (MACE) model derived from the Best Endovascular versus Best Surgical Therapy in patients with critical limb ischemia (BEST-CLI) cohort on the real-world database from the vascular quality initiative (VQI) and Vascular Implant Surveillance and Interventional Outcomes Network (VISION). METHODS: We applied the BEST-CLI MACE model to compare the observed versus expected rate of 1-year MACE defined as death, myocardial infarction (MI), and cerebrovascular accident (CVA) in patients within the VQI-VISION Peripheral Vascular Intervention and Infrainguinal Registries (2016-2019). Kaplan-Meier analysis was performed to calculate the observed 1-year rate of MACE. Model calibration and discrimination were assessed with Cox calibration slope and intercept with Harrel's C-index. RESULTS: We identified 19,144 eligible patients (endovascular n=14,878, 77.7%; open n=4,266, 22.3%) from the VQI-VISION database. Kaplan-Meier estimated 1-year mortality was 25.3% (95% confidence interval [CI] 24.6%-25.9%), MI 10.3% (95% CI 9.8%-10.8%), and CVA 4.9% (95% CI 4.6%-5.3%), with a composite MACE of 32.6% (95% CI 31.9%-33.3%). BEST-CLI MACE scores ranged between -4 and 23 (median patient score = 9, interquartile range: 5-13). The mean deviation between the observed 1-year MACE from the VQI-VISION compared to BEST-CLI estimated MACE was 8.6% (95% CI 8.5%-8.7%) higher. The model calibration slope was 0.54, intercept was 0.31, and discrimination C-index was 0.62. CONCLUSION: This external validation of the BEST-CLI 1-year MACE scoring system suggests modest predictive ability in real-world vascular practice with the model underestimating 1-year MACE on average by 8.6%.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Patel NTP, Mouradian G, Ferris MB, et al. External Validation of the BEST-CLI Major Adverse Cardiac Risk Calculator in the Vascular Quality Initiative and Vascular Implant Surveillance and Interventional Outcomes Network. Ann Vasc Surg. 2026. PMID: 42508729. doi:10.1016/j.avsg.2026.07.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。